TREM-1 and DAP12 expression in monocytes of patients with severe psychiatric disorders. EGR3, ATF3 and PU.1 as important transcription factors

Brain, Behavior, and Immunity

Volumn 25, Issue 6, 2011, Pages 1162-1169

  Weigelt, Karin ^a   Carvalho, Livia A ^b   Drexhage, Roos C ^a   Wijkhuijs, Annemarie ^a   Wit, Harm de ^a   van Beveren, Nico J M ^a   Birkenhäger, Tom K ^a   Bergink, Veerle ^a   Drexhage, Hemmo A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

ATF3; EGR3; Inflammation; Monocytes; Psychiatry; TREM 1

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 3; ADAPTOR PROTEIN; ADAPTOR PROTEIN DAP12; EARLY GROWTH RESPONSE FACTOR 3; TRANSCRIPTION FACTOR PU 1; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BINDING SITE; BIPOLAR DISORDER; CHROMATIN IMMUNOPRECIPITATION; COMPUTER MODEL; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; IN VIVO STUDY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL DISEASE; MONOCYTE; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SCHIZOPHRENIA;

ACTIVATING TRANSCRIPTION FACTOR 3; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; BIPOLAR DISORDER; CHROMATIN IMMUNOPRECIPITATION; DEPRESSIVE DISORDER, MAJOR; EARLY GROWTH RESPONSE PROTEIN 3; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INPATIENTS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MIDDLE AGED; MONOCYTES; NEUROIMMUNOMODULATION; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS; PSYCHOTROPIC DRUGS; RECEPTORS, IMMUNOLOGIC; SCHIZOPHRENIA; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; YOUNG ADULT;

EID: 79960242993     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2011.03.006     Document Type: Article

References (82)

1. Andreasen N.C., Flaum M., Arndt S. The Comprehensive Assesment of Symptoms and History (CASH). An instrument for assesing diagnosis and psychopathology. Arch. Gen. Psychiatry 1992, 49:615-623.
2. Anderson K.L., Perkin H., Surh C.D., Venturini S., Maki R.A., Torbett B.E. Transcription factor PU.1 is necessary for development of thymic and myeloid progenitor-derived dendritic cells. J. Immunol. 2000, 164:1855-1861.
3. Bamias G., Martin C., Marini M., Hoang S., Mishina M., Ross W.G., Sachedina M.A., Friel C.M., Mize J., Bickston S.J., Pizarro T.T., Wei P., Cominelli F. Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease. J. Immunol. 2003, 171:4868-4874.
4. Beillard E., Pallisgaard N., van der Velden V.H., Bi W., Dee R., van der Schoot E., Delabesse E., Macintyre E., Gottardi E., Saglio G., Watzinger F., Lion T., van Dongen J.J., Hokland P., Gabert J. Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program. Leukemia 2003, 17:2474-2486.
5. Bessis A., Bechade C., Bernard D., Roumier A. Microglial control of neuronal death and synaptic properties. Glia 2007, 55:233-238.
6. Beyan H., Drexhage R.C., l Nieuwenhuijsen L., de Wit H., Padmos R.C., Schloot N.C., Drexhage H.A., Leslie R.D. Monocyte gene-expression profiles associated with childhood-onset type 1 diabetes and disease risk: a study of identical twins. Diabetes 2010, 59:1751-1755.
7. Bouchon A., Dietrich J., Colonna M. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J. Immunol. 2000, 164:4991-4995.
8. Bouchon A., Facchetti F., Weigand M.A., Colonna M. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 2001, 410:1103-1107.
9. Carter J.H., Tourtellotte W.G. Early growth response transcriptional regulators are dispensable for macrophage differentiation. J. Immunol. 2007, 178:3038-3047.
10. Chen S.K., Tvrdik P., Peden E., Cho S., Wu S., Spangrude G., Capecchi M.R. Hematopoietic origin of pathological grooming in Hoxb8 mutant mice. Cell 2010, 141:775-785.
11. Cole S.W., Hawkley L.C., Arevalo J.M., Sung C.Y., Rose R.M., Cacioppo J.T. Social regulation of gene expression in human leukocytes. Genome Biol. 2007, 8:R189.
12. Dantzer R. Cytokine-induced sickness behavior: mechanisms and implications. Ann. NY Acad. Sci. 2001, 933:222-234.
13. del Fresno C., Gomez-Pina V., Lores V., Soares-Schanoski A., Fernandez-Ruiz I., Rojo B., Alvarez-Sala R., Caballero-Garrido E., Garcia F., Veliz T., Arnalich F., Fuentes-Prior P., Garcia-Rio F., Lopez-Collazo E. Monocytes from cystic fibrosis patients are locked in an LPS tolerance state: down-regulation of TREM-1 as putative underlying mechanism. PLoS One 2008, 3:e2667.
14. Doorduin J., de Vries E.F., Willemsen A.T., de Groot J.C., Dierckx R.A., Klein H.C. Neuroinflammation in schizophrenia-related psychosis: a PET study. J. Nucl. Med. 2009, 50:1801-1807.
15. Dower K., Ellis D.K., Saraf K., Jelinsky S.A., Lin L.L. Innate immune responses to TREM-1 activation: overlap, divergence, and positive and negative cross-talk with bacterial lipopolysaccharide. J. Immunol. 2008, 180:3520-3534.
16. Drexhage, R.C., van der Heul-Nieuwenhuijsen, L., Padmos, R.C., van Beveren, N., Cohen, D., Versnel, M.A., Nolen, W.A., Drexhage, H.A., 2010. Inflammatory gene expression in monocytes of patients with schizophrenia: overlap and difference with bipolar disorder. A study in naturalistically treated patients. Int. J. Neuropsychopharmacol./Official Sci. J. Collegium Internationale Neuropsychopharmacologicum (CINP), 1-13.
17. Dunn A.J., Swiergiel A.H., de Beaurepaire R. Cytokines as mediators of depression: what can we learn from animal studies?. Neurosci. Biobehav. Rev. 2005, 29:891-909.
18. Eisenberger N.I., Inagaki T.K., Mashal N.M., Irwin M.R. Inflammation and social experience.: an inflammatory challenge induces feelings of social disconnection in addition to depressed mood. Brain Behav. Immun. 2010, 24:558-563.
19. Eldredge L.C., Gao X.M., Quach D.H., Li L., Han X., Lomasney J., Tourtellotte W.G. Abnormal sympathetic nervous system development and physiological dysautonomia in Egr3-deficient mice. Development 2008, 135:2949-2957.
20. Eramaa M., Hurme M., Stenman U.H., Ritvos O. Activin A/erythroid differentiation factor is induced during human monocyte activation. J. Exp. Med. 1992, 176:1449-1452.
21. First MB, S.R., Gibbon, M., Williams, J.B.W. (Eds.), 1999. Structured Clinical Interview for DSM IV Axis I Disorders, Patient Edition (Nederlandse Versie). Swets and Zeitlinger, BV: Lisse, Nederland.
22. Gallant S., Gilkeson G. ETS transcription factors and regulation of immunity. Arch. Immunol. Ther. Exp. (Warsz) 2006, 54:149-163.
23. Gallitano-Mendel A., Izumi Y., Tokuda K., Zorumski C.F., Howell M.P., Muglia L.J., Wozniak D.F., Milbrandt J. The immediate early gene early growth response gene 3 mediates adaptation to stress and novelty. Neuroscience 2007, 148:633-643.
24. Gallitano-Mendel A., Wozniak D.F., Pehek E.A., Milbrandt J. Mice lacking the immediate early gene Egr3 respond to the anti-aggressive effects of clozapine yet are relatively resistant to its sedating effects. Neuropsychopharmacology 2008, 33:1266-1275.
25. Ghisletti S., Barozzi I., Mietton F., Polletti S., De Santa F., Venturini E., Gregory L., Lonie L., Chew A., Wei C.L., Ragoussis J., Natoli G. Identification and characterization of enhancers controlling the inflammatory gene expression program in macrophages. Immunity 2010, 32:317-328.
26. Gibot S., Kolopp-Sarda M.N., Bene M.C., Bollaert P.E., Lozniewski A., Mory F., Levy B., Faure G.C. A soluble form of the triggering receptor expressed on myeloid cells-1 modulates the inflammatory response in murine sepsis. J. Exp. Med. 2004, 200:1419-1426.
27. Gilchrist M., Thorsson V., Li B., Rust A.G., Korb M., Roach J.C., Kennedy K., Hai T., Bolouri H., Aderem A. Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4. Nature 2006, 441:173-178.
28. Gomez-Pina V., Soares-Schanoski A., Rodriguez-Rojas A., Del Fresno C., Garcia F., Vallejo-Cremades M.T., Fernandez-Ruiz I., Arnalich F., Fuentes-Prior P., Lopez-Collazo E. Metalloproteinases shed TREM-1 ectodomain from lipopolysaccharide-stimulated human monocytes. J. Immunol. 2007, 179:4065-4073.
29. Greenberg D.B., Jonasch E., Gadd M.A., Ryan B.F., Everett J.R., Sober A.J., Mihm M.A., Tanabe K.K., Ott M., Haluska F.G. Adjuvant therapy of melanoma with interferon-alpha-2b is associated with mania and bipolar syndromes. Cancer 2000, 89:356-362.
30. Gribi R., Tanaka T., Harper-Summers R., Yu J. Expression of activin A in inflammatory arthropathies. Mol. Cell. Endocrinol. 2001, 180:163-167.
31. Grinberg A.V., Hu C.D., Kerppola T.K. Visualization of Myc/Max/Mad family dimers and the competition for dimerization in living cells. Mol. Cell Biol. 2004, 24:4294-4308.
32. Guerriero A., Langmuir P.B., Spain L.M., Scott E.W. PU.1 is required for myeloid-derived but not lymphoid-derived dendritic cells. Blood 2000, 95:879-885.
33. Guo A.Y., Sun J., Jia P., Zhao Z. A novel microRNA and transcription factor mediated regulatory network in schizophrenia. BMC Sys. Bio. 2010, 4:10.
34. Hamerman, J.A., Lanier, L.L., 2006. Inhibition of immune responses by ITAM-bearing receptors. Sci. STKE 2006, re1.
35. Hubner G., Brauchle M., Gregor M., Werner S. Activin A: a novel player and inflammatory marker in inflammatory bowel disease?. Lab. Invest. 1997, 77:311-318.
36. Innamorato N.G., Rojo A.I., Garcia-Yague A.J., Yamamoto M., de Ceballos M.L., Cuadrado A. The transcription factor Nrf2 is a therapeutic target against brain inflammation. J. Immunol. 2008, 181:680-689.
37. Innamorato N.G., Lastres-Becker I., Cuadrado A. Role of microglial redox balance in modulation of neuroinflammation. Curr. Opin. Neurol. 2009, 22:308-314.
38. Johnson D.A., Amirahmadi S., Ward C., Fabry Z., Johnson J.A. The absence of the pro-antioxidant transcription factor Nrf2 exacerbates experimental autoimmune encephalomyelitis. Toxicol. Sci. 2010, 114:237-246.
39. Kim S.H., Song J.Y., Joo E.J., Lee K.Y., Ahn Y.M., Kim Y.S. EGR3 as a potential susceptibility gene for schizophrenia in Korea. Am. J. Med. Genet. B Neuropsychiatry Genet. 2010, 153B:1355-1360.
40. Klesney-Tait J., Colonna M. Uncovering the TREM-1-TLR connection. Am. J. Physiol. Lung Cell Mol. Physiol. 2007, 293:L1374-1376.
41. Knapp S., Gibot S., de Vos A., Versteeg H.H., Colonna M., van der Poll T. Cutting edge: expression patterns of surface and soluble triggering receptor expressed on myeloid cells-1 in human endotoxemia. J. Immunol. 2004, 173:7131-7134.
42. Knijff E.M., Breunis M.N., van Geest M.C., Kupka R.W., Ruwhof C., de Wit H.J., Nolen W.A., Drexhage H.A. A relative resistance of T cells to dexamethasone in bipolar disorder. Bipolar Disord. 2006, 8:740-750.
43. Kong X., Thimmulappa R., Kombairaju P., Biswal S. NADPH oxidase-dependent reactive oxygen species mediate amplified TLR4 signaling and sepsis-induced mortality in Nrf2-deficient mice. J. Immunol. 2010, 185:569-577.
44. Laslo P., Spooner C.J., Warmflash A., Lancki D.W., Lee H.J., Sciammas R., Gantner B.N., Dinner A.R., Singh H. Multilineage transcriptional priming and determination of alternate hematopoietic cell fates. Cell 2006, 126:755-766.
45. Li L., Yun S.H., Keblesh J., Trommer B.L., Xiong H., Radulovic J., Tourtellotte W.G. Egr3, a synaptic activity regulated transcription factor that is essential for learning and memory. Mol. Cell Neurosci. 2007, 35:76-88.
46. Lloberas J., Soler C., Celada A. The key role of PU.1/SPI-1 in B cells, myeloid cells and macrophages. Immunol. Today 1999, 20:184-189.
47. Lyons P.A., Koukoulaki M., Hatton A., Doggett K., Woffendin H.B., Chaudhry A.N., Smith K.G. Microarray analysis of human leucocyte subsets: the advantages of positive selection and rapid purification. BMC Genomics 2007, 8:64.
48. McKercher S.R., Torbett B.E., Anderson K.L., Henkel G.W., Vestal D.J., Baribault H., Klemsz M., Feeney A.J., Wu G.E., Paige C.J., Maki R.A. Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J. 1996, 15:5647-5658.
49. Miller A.H., Maletic V., Raison C.L. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol. Psychiatry 2009, 65:732-741.
50. Motohashi H., Shavit J.A., Igarashi K., Yamamoto M., Engel J.D. The world according to Maf. Nucleic Acids Res. 1997, 25:2953-2959.
51. Motohashi H., Katsuoka F., Engel J.D., Yamamoto M. Small Maf proteins serve as transcriptional cofactors for keratinocyte differentiation in the Keap1-Nrf2 regulatory pathway. Proc. Nat. Acad. Sci. USA 2004, 101:6379-6384.
52. Myers T.A., Kaushal D., Philipp M.T. Microglia are mediators of Borrelia burgdorferi-induced apoptosis in SH-SY5Y neuronal cells. PLoS Pathog. 2009, 5:e1000659.
53. Narayan S., Tang B., Head S.R., Gilmartin T.J., Sutcliffe J.G., Dean B., Thomas E.A. Molecular profiles of schizophrenia in the CNS at different stages of illness. Brain Res. 2008, 1239:235-248.
54. Otero K., Turnbull I.R., Poliani P.L., Vermi W., Cerutti E., Aoshi T., Tassi I., Takai T., Stanley S.L., Miller M., Shaw A.S., Colonna M. Macrophage colony-stimulating factor induces the proliferation and survival of macrophages via a pathway involving DAP12 and beta-catenin. Nat. Immunol. 2009, 10:734-743.
55. Padmos R.C., Hillegers M.H., Knijff E.M., Vonk R., Bouvy A., Staal F.J., de Ridder D., Kupka R.W., Nolen W.A., Drexhage H.A. A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes. Arch. Gen. Psychiatry 2008, 65:395-407.
56. Post R.M., Nolen W.A., Kupka R.W., Denicoff K.D., Leverich G.S., Keck P.E., McElroy S.L., Rush A.J., Suppes T., Altshuler L.L., Frye M.A., Grunze H., Walden J. The Stanley Foundation Bipolar Network. I. Rationale and methods. Br. J. Psychiatry 2001, 41:s169-176.
57. Potvin S., Stip E., Sepehry A.A., Gendron A., Bah R., Kouassi E. Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol. Psychiatry 2008, 63:801-808.
58. Reichenberg A., Yirmiya R., Schuld A., Kraus T., Haack M., Morag A., Pollmacher T. Cytokine-associated emotional and cognitive disturbances in humans. Arch. Gen. Psychiatry 2001, 58:445-452.
59. Rojo A.I., Innamorato N.G., Martin-Moreno A.M., De Ceballos M.L., Yamamoto M., Cuadrado A. Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson's disease. Glia 2010, 58:588-598.
60. Schuld A., Hinze-Selch D., Pollmacher T. [Cytokine network in patients with schizophrenia and its significance for the pathophysiology of the illness] Zytokinnetzwerke bei Patienten mit Schizophrenie und ihre Bedeutung fur die Pathophysiologie der Erkrankung. Nervenarzt 2004, 75:215-226.
61. Scott E.W., Simon M.C., Anastasi J., Singh H. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 1994, 265:1573-1577. (New York, N.Y).
62. Scott E.W., Fisher R.C., Olson M.C., Kehrli E.W., Simon M.C., Singh H. PU.1 functions in a cell-autonomous manner to control the differentiation of multipotential lymphoid-myeloid progenitors. Immunity 1997, 6:437-447.
63. Sharif O., Bolshakov V.N., Raines S., Newham P., Perkins N.D. Transcriptional profiling of the LPS induced NF-kappaB response in macrophages. BMC Immunol. 2007, 8:1.
64. Smith R.S. A comprehensive macrophage-T-lymphocyte theory of schizophrenia. Med. Hypotheses 1992, 39:248-257.
65. Smith R.S., Maes M. The macrophage-T-lymphocyte theory of schizophrenia: additional evidence. Med. Hypotheses 1995, 45:135-141.
66. Staal F.J., Weerkamp F., Baert M.R., van den Burg C.M., van Noort M., de Haas E.F., van Dongen J.J. Wnt target genes identified by DNA microarrays in immature CD34+ thymocytes regulate proliferation and cell adhesion. J. Immunol. 2004, 172:1099-1108.
67. Svaren J., Sevetson B.R., Golda T., Stanton J.J., Swirnoff A.H., Milbrandt J. Novel mutants of NAB corepressors enhance activation by Egr transactivators. EMBO J. 1998, 17:6010-6019.
68. Tabares-Seisdedos R., Rubenstein J.L. Chromosome 8p as a potential hub for developmental neuropsychiatric disorders: implications for schizophrenia, autism and cancer. Mol. Psychiatry 2009, 14:563-589.
69. Tessarz A.S., Cerwenka A. The TREM-1/DAP12 pathway. Immunol. Lett. 2008, 116:111-116.
70. Thimmulappa R.K., Lee H., Rangasamy T., Reddy S.P., Yamamoto M., Kensler T.W., Biswal S. Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis. J. Clin. Invest. 2006, 116:984-995.
71. Tourtellotte W.G., Nagarajan R., Bartke A., Milbrandt J. Functional compensation by Egr4 in Egr1-dependent luteinizing hormone regulation and Leydig cell steroidogenesis. Mol. Cell Biol. 2000, 20:5261-5268.
72. Turnbull I.R., Colonna M. Activating and inhibitory functions of DAP12. Nat. Rev. Immunol. 2007, 7:155-161.
73. van der Heul-Nieuwenhuijsen L., Padmos R.C., Drexhage R.C., de Wit H., Berghout A., Drexhage H.A. An inflammatory gene-expression fingerprint in monocytes of autoimmune thyroid disease patients. J. Clin. Endocrinol. Metab. 2010, 95:1962-1971.
74. Walsh J.C., DeKoter R.P., Lee H.J., Smith E.D., Lancki D.W., Gurish M.F., Friend D.S., Stevens R.L., Anastasi J., Singh H. Cooperative and antagonistic interplay between PU.1 and GATA-2 in the specification of myeloid cell fates. Immunity 2002, 17:665-676.
75. Walton M.R., Gibbons H., MacGibbon G.A., Sirimanne E., Saura J., Gluckman P.D., Dragunow M. PU.1 expression in microglia. J. Neuroimmunol. 2000, 104:109-115.
76. Weigelt K., Ernst W., Walczak Y., Ebert S., Loenhardt T., Klug M., Rehli M., Weber B.H., Langmann T. Dap12 expression in activated microglia from retinoschisin-deficient retina and its PU.1-dependent promoter regulation. J. Leukoc. Biol. 2007, 82:1564-1574.
77. Weigelt K., Lichtinger M., Rehli M., Langmann T. Transcriptomic profiling identifies a PU.1 regulatory network in macrophages. Biochem. Biophys. Res. Commun. 2009, 380:308-312.
78. Wright C.E., Strike P.C., Brydon L., Steptoe A. Acute inflammation and negative mood: mediation by cytokine activation. Brain Behav. Immun. 2005, 19:345-350.
79. Yamada K., Gerber D.J., Iwayama Y., Ohnishi T., Ohba H., Toyota T., Aruga J., Minabe Y., Tonegawa S., Yoshikawa T. Genetic analysis of the calcineurin pathway identifies members of the EGR gene family, specifically EGR3, as potential susceptibility candidates in schizophrenia. Proc. Nat. Acad. Sci. USA 2007, 104:2815-2820.
80. Ye X., Li Y., Huang Q., Yu Y., Yuan H., Wang P., Wan D., Gu J., Huo K., Li Y.Y., Lu H. The novel human gene MIP functions as a co-activator of hMafF. Arch. Biochem. Biophys. 2006, 449:87-93.
81. Yu E.W., Dolter K.E., Shao L.E., Yu J. Suppression of IL-6 biological activities by activin A and implications for inflammatory arthropathies. Clin. Exp. Immunol. 1998, 112:126-132.
82. Zeng H., Ornatowska M., Joo M.S., Sadikot R.T. TREM-1 expression in macrophages is regulated at transcriptional level by NF-kappaB and PU.1. Eur. J. Immunol. 2007, 37:2300-2308.